ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Full Compliance With Adjuvant Endocrine Therapy Brings 15 Percent Superior Survival in Patients With Breast Cancer"
Episode Synopsis
Patients with breast cancer who complied fully with their adjuvant endocrine medication lived 15 percent longer than those who skipped doses, according to a huge real-world study coordinated from Tübingen University, in Baden-Württemberg, Germany, reported at the 2023 ASCO Annual Meeting.
OncTimesTalk correspondent Peter Goodwin discusses the findings with senior author of the study, Dominik Dannehl, MD, a physician at the Department of Women's Health, Tübingen University Hospital, in Tübingen, Baden-Württemberg, Germany.
OncTimesTalk correspondent Peter Goodwin discusses the findings with senior author of the study, Dominik Dannehl, MD, a physician at the Department of Women's Health, Tübingen University Hospital, in Tübingen, Baden-Württemberg, Germany.
In God we trust